Application of IGKC, C9, AHSG and KNG1 in distinguishing tuberculous pleural effusion and malignant pleural effusion
A technology for malignant pleural effusion and pleural effusion, applied in the biological field, can solve the problems of false positive, false negative, difficult to popularize, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0066] Example 1. Differential proteins in patients with tuberculous pleural effusion and malignant pleural effusion
[0067] 1. Discovery of differential proteins between patients with tuberculous pleural effusion and malignant pleural effusion
[0068] 1. Samples and instruments
[0069] 5 cases were selected from TPE (tuberculous pleural effusion) patients, and the other 5 cases were MPE (malignant pleural effusion) patients, all of which were confirmed by laboratory and clinical diagnosis reports.
[0070] Patients with tuberculous pleural effusion, inclusion criteria: age ≥ 18 years old, HIV negative. Those who have the following items 1 to 3 combined with any of items 4 to 6 can be included: ① Clinical symptoms such as low fever, night sweats, weight loss, chest pain, dry cough, etc.; ② Pleural effusion consistent with exudate changes, pleural effusion cells The main components are lymphocytes and monocytes, and the adenosine deaminase (ADA) in pleural effusion is grea...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com